Trials / Withdrawn
WithdrawnNCT04567095
A Study to Evaluate Awareness and Knowledge of the Fibristal Additional Risk Minimization Measures Among Patients in Canada
A Cross-sectional Study Among Patients in Canada to Assess Awareness and Knowledge of the Fibristal Patient Alert Card
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- Allergan · Industry
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a non-interventional, cross-sectional survey study to evaluate the effectiveness of the Additional Risk Minimization Measures for Fibristal among Patients in Canada.
Detailed description
Data will be collected via web-based data capture and paper surveys depending on patient preference. The survey will be conducted in a single wave over 6 months. All data will be maintained in compliance with local regulations.
Conditions
Timeline
- Start date
- 2020-10-31
- Primary completion
- 2021-06-30
- Completion
- 2021-06-30
- First posted
- 2020-09-28
- Last updated
- 2020-10-23
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04567095. Inclusion in this directory is not an endorsement.